Regeneron Pharmaceuticals Inc Revenue per Employee (REGN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Regeneron Pharmaceuticals Inc   (NASDAQ: REGN)
 

Regeneron Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Regeneron Pharmaceuticals Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,008,092, below the company average number of $495,878.
Within the Healthcare sector Employees of 82 other companies have achieved higher revenue per employee. While Regeneron Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 248 to 894. Regeneron Pharmaceuticals Inc has 15,410 employees.


What is Sales per Employee Ratio?







REGN Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 16.73 % 19.04 % 2.51 % 0.9 % 3.62 %
Sales per Employee (TTM) $ 1,008,092 968,177 930,753 924,581 922,401
REGN's Total Ranking # 894 # 248 # 98 # 75 # 279
Seq. Revenue Change 19.01 % -7.18 % 3.46 % 2.14 % 21.36 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 57
Healthcare Sector # 83
Overall Market # 894

Revenue per Employee Statistics
High Average Low
$ 1,071,259 $ 495,878 $ 28,931
(Mar 31 2022)   (Dec 31 2011)



Financial Statements
Regeneron Pharmaceuticals Inc 's Revenue MRQ $ 4,291 Millions Visit REGN's Income Statement
Regeneron Pharmaceuticals Inc 's Revenues TTM $ 15,535 Millions Visit REGN's aggregate revenue growth
What are REGN's Sales? Visit REGN's Sales by Segment




Other Ratios
Regeneron Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
REGN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for REGN's Competitors
Revenue per Employee for REGN's Suppliers
Revenue per Employee for REGN's Customers

You may also want to know
REGN's Sales Growth Rates REGN's Pe Price to earnings ratio REGN's Receivables Turnover Ratio REGN's Stock Quote
REGN's Net Income Growth Rates REGN's Ps Price to Sales ratio REGN's Sales per Employee REGN's Asset Turnover Ratio
REGN's Net Margin REGN's Pb Price to Book ratio REGN's Financial Strength Ratios REGN's Dividend Payout Ratio
Date modified: 2026-09-15T07:24:37+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Eli Lilly And Company  1,593,316.00 $ 79,665.800  Million 50,000 
Jazz Pharmaceuticals Plc  1,592,122.15 $ 4,601.233  Million 2,890 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 
Bristol myers Squibb Company  1,513,415.38 $ 49,186.000  Million 32,500 
Krystal Biotech Inc   1,493,166.10 $ 440.484  Million 295 
Acadia Pharmaceuticals Inc   1,426,870.93 $ 1,138.643  Million 798 
Madrigal Pharmaceuticals Inc   1,403,213.11 $ 1,283.940  Million 915 
Indivior Pharmaceuticals Inc   1,333,000.00 $ 1,333.000  Million 1,000 
Arcutis Biotherapeutics Inc   1,310,680.79 $ 463.981  Million 354 
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Puma Biotechnology Inc   1,291,865.92 $ 231.244  Million 179 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Supernus Pharmaceuticals inc   1,273,677.91 $ 830.438  Million 652 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Abbvie Inc   1,129,578.95 $ 64,386.000  Million 57,000 
Akebia Therapeutics Inc   1,129,175.26 $ 219.060  Million 194 
Siga Technologies Inc  1,095,079.92 $ 53.659  Million 49 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.